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Abstract 
Determining whether associations between lifestyle behaviours and health outcomes 
are causal is difficult in observational data. However, as genetic variants associated with 
these behaviours are discovered, this will provide opportunities for testing causality using 
Mendelian randomization methods.  These use genetic variants as proxies for exposures to 
minimise biases associated with observational data, enabling stronger causal inference. 
Here we review the principles and main approaches for conducting Mendelian randomization 
studies, and discuss recent methodological developments for investigating more complex 
causal pathways. Mendelian randomization offers considerable promise for improving our 
understanding of the causal relationships between lifestyle behaviours and health outcomes, 
and its application will increase as more genetic variants robustly associated with 
behavioural phenotypes are identified. 
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Using Genetic Information to Infer Causality in Observational Data: 
Mendelian Randomization 
 
Genome-wide association studies (GWAS) are revealing genetic variants associated 
with phenotypes such as tobacco use [1-3], obesity [4] and educational attainment [5]. These 
findings have advanced our understanding of the neurobiological basis of these phenotypes 
[6], but also offer the opportunity to use this information to make causal inferences regarding 
their effects on a range of outcomes. Mendelian randomization (MR) is based on 
instrumental variable (IV) methods developed in the economics literature, and aims to 
minimise problems of measurement bias, confounding and reverse causality intrinsic to 
observational studies. IV analysis requires a variable that is a proxy or instrument for the 
exposure of interest, which must meet a number of criteria: 1) association with the exposure 
of interest; 2) no association with the outcome of interest, apart from via the exposure; 3) no 
association with confounders affecting the relationship under investigation; and, 4) unable to 
introduce potential confounding in to the relationship [7]. Given an appropriate instrument, 
confounders will be randomly distributed across the conditions of interest in the same way as 
a randomized trial – (see Figure 1). This is particularly important in observational studies; 
confounders may be difficult to adequately adjust for, and some may be impossible to 
measure or unknown [8]. An ideal instrument would be unrelated to measured or 
unmeasured confounders, known or unknown. 
 
Insert Figure 1 about here. 
 
Mendelian Randomization 
Mendelian randomization uses genetic variants as instruments for environmental 
exposures [9,10]. These can take the form of individual single nucleotide polymorphisms 
(SNPs), or polygenic risk scores, which must be robustly associated with the exposure of 
interest (e.g., smoking heaviness or alcohol use) (see Figure 2). The principle of MR relies 
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on the basic (but approximate) laws of Mendelian genetics (segregation and independent 
assortment). If these hold then, at a population level, genetic variants will not be associated 
with potential confounders [11,12]. The SNP or risk score must also not directly affect the 
outcome being investigated. Certain exposures, such as number of cigarettes or amount of 
alcohol consumed, allow for this assumption to be tested, as the effect of gene on the 
outcome can be assessed in those unexposed to the putative causal risk factor. For 
example, if a gene meant to be a proxy for number of cigarettes smoked has a relationship 
with an outcome in those who have never smoked, this suggests a direct effect of the gene. 
 
Insert Figure 2 about here. 
 
SNPs or risk scores have other potential benefits over observational studies. For 
example, genes act on exposures over a long period, and therefore better index long-term 
environmental exposure than self-report measures taken at a specific time point. Also, MR 
effectively rules out reverse causation: the outcome cannot affect genotype. Therefore, if 
specific genetic variants associated with environmental exposures are identified, it may be 
possible to use MR to explore the causal effects of those exposures. Where variants have 
been identified, MR studies have already been undertaken, for example looking at the 
effects of alcohol use [13,14] and tobacco use [15-18]. These have provided evidence that 
maternal alcohol drinking in pregnancy adversely impacts offspring educational outcomes 
[13], that alcohol consumption increases blood pressure and body mass index (BMI) [14], 
that smoking lowers BMI [15], and that maternal smoking in pregnancy reduces offspring 
birth weight [18]. 
MR can enable causal inference in two broad ways (See Figure 3). First, a direct 
association between a genetic instrument and the outcome of interest can provide evidence 
for the existence of a causal relationship between exposure and outcome. Second, the 
magnitude of the association between a genetic variant and the exposure, and between the 
genetic variant and outcome, can be used to estimate the magnitude of the causal effect of 
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the exposure on the outcome (using methods such as two stage least squares regression). 
As genotype will affect exposure over a lifetime, MR can in principle allow for more accurate 
estimation of the magnitude of a causal effect than a direct assessment taken at a single 
time point [19] although for the same reason it may over-estimate the likely magnitude of an 
intervention effect. For example, an intervention delivered in middle age will only partially 
reduce the lifetime exposure to a risk factor that is estimated from MR analyses. 
 
Insert Figure 3 about here. 
 
Two Sample Mendelian Randomization 
Commonly, the association between a genetic variant and the exposure, and between 
the genetic variant and the outcome, are estimated in the same sample. However, this may 
not always be possible if exposure and outcomes are not measured in the same samples, or 
if the exposure has only been measured in a subset of the total sample [20]. In two sample 
MR, the genotype-exposure and genotype-outcome associations are estimated in different 
samples and these estimates then combined to provide an estimate of the causal exposure-
outcome association [21]. As both of these parameters are estimates, the standard error of 
the exposure-outcome association needs to be adjusted using appropriate methods [20]. 
Two sample MR does not usually lead to a substantial loss of statistical power [21], so this 
type of design may be a more cost effective approach [20]. 
 
Two-Step Mendelian Randomization 
 Establishing that an association is causal is valuable in itself, but of potentially 
greater interest is establishing the mechanism through which this causal association 
operates.  It may be possible to investigate causal mechanisms between an exposure and 
an outcome using a two-step MR approach [22]. This type of analysis requires a genetic 
variant which associates with the exposure of interest and a separate genetic variant which 
associates with the mediating factor of interest. For example, there is growing interest in the 
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role of epigenetic mediators of environmental exposures, but epigenetic markers (as with 
any other biomarker) are vulnerable to confounding and reverse causality. Here, a genetic 
proxy for the exposure of interest is used to assess the causal relationship between the 
environmental exposure and a potential mediator such as methylation (step 1, see Figure 
4A). Next, a genetic proxy for the mediator (here, DNA methylation) is used to interrogate 
the causal relationship between the mediator and the outcome of interest (step 2, see Figure 
4B). This approach enables a triangulation of evidence to infer a mediating role for, in this 
case, methylation in the causal pathway between the environmental exposure and the 
outcome of interest. It can in principle be applied to other potential mediators (e.g., 
metabolite levels). 
 
Insert Figure 4 about here. 
 
Bidirectional and Network Mendelian Randomization 
 Early MR studies focused on a single direction of causality, such as the effects of 
alcohol consumption on cardiovascular risk [14], but in many cases the relationship may be 
bidirectional. For example, tobacco use has been shown to lower BMI [15], but BMI may also 
affect smoking behaviour if individuals smoke in order to control their weight. In cases such 
as this, where genetic instruments for both the exposure and the outcome are available, MR 
analysis may be performed in both directions. Bidirectional MR has been used previously to 
investigate the direction of causality between BMI and a number of other factors, including 
vitamin D and C-reactive protein levels [23,24]. A more complex problem arises when 
multiple phenotypes that may influence each other in a causal network are considered. 
Methods are currently being developed, using multiple genetic variants, which allow 
assessment of causal directions in pathways with correlated phenotypes [20, 25, 26]. 
 
Limitations to Mendelian Randomization 
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MR studies require much larger sample sizes than conventional exposure-outcome 
analyses. As a general rule, sample sizes for MR studies can be calculated by multiplying 
the required observational sample size by the inverse of the variance (R2 or square of the 
correlation coefficient) in the exposure of interest explained by the genetic instrument. For 
example, for a genetic variant explaining 1% of the variance in an exposure, the sample size 
would need to be 100 times greater than the sample size required to detect the true causal 
effect between the directly measured exposure and the outcome. Statistical code and online 
calculators are now available for determination of sample sizes required for MR studies for 
both continuous and categorical outcomes [27-29]. Whilst collaborative consortia (see Text 
Box 1) offer a potential solution to the issue of power in MR studies, combining phenotypic 
outcomes across many different studies can be challenging, particularly for behavioural 
exposures and outcomes. 
 
Insert Text Box 1 about here. 
 
It is also only possible to use MR to study the effects of exposures for which genetic 
variants have been identified. Whilst GWAS have been successful in identifying variants that 
influence a number of traits, there are still many exposures for which we do not yet have 
suitable instruments. In addition, genetic variants may be population-specific and not 
suitable for use in all ancestral groups. For example, a variant in the ALDH2 gene, which 
strongly influences alcohol consumption, is used in MR studies in East Asian populations, 
but occurs at too low a frequency for use in MR studies in European populations [30]. 
Critically, genetic variants in MR studies must be associated with the exposure of interest 
within the analysis sample and must show robust evidence for association with the same 
exposure in independent samples. Performing MR analyses using genetic instruments that 
have been discovered within the analysis sample but have not been independently 
replicated can lead to causal inference in the absence of true causal effects, because 
associations between genetic variants and exposures may just be chance findings. In 
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addition, as effect sizes between genetic variants and phenotypes are often inflated in 
discovery samples (also known as the Beavis effect or Winner’s Curse), performing MR 
analyses within discovery samples can result in biased causal effect sizes [31].  
Biased estimates of effect sizes may also be obtained if the measured exposure 
does not fully capture the causal exposure through which the genetic variant operates [31]. 
For example, a variant in the nicotinic receptor alpha-5 subunit protein, rs16969968, 
influences lifetime tobacco exposure, but this is not well captured by self-report measures of 
smoking (e.g., cigarettes per day). MR of lung cancer data using cigarettes per day as the 
intermediate variable indicates a causal odds ratio for lung cancer of 2,180 per pack of 
cigarettes smoked per day, compared to only 2.6 from observational analysis [32]. In 
contrast, using cotinine, a metabolite of nicotine and a more precise objective measure of 
tobacco exposure, produce effect sizes which are more consistent with observational 
findings [33]. In the absence of appropriate intermediate exposure measures, MR can still be 
used to infer causality, but it may not be possible to accurately estimate causal magnitudes 
of effect. Furthermore, MR studies can be informative about the effects of lifelong exposure 
to a risk factor, but are usually not appropriate for investigating the impact of short-term 
changes in risk factors on health outcomes. MR studies will also rarely provide information 
about the mechanisms underlying a causal relationship (although two-step MR can provide 
this). 
Whilst MR can minimise many of the biases associated with conventional 
epidemiological studies, there are ways in which MR can still be confounded. Spurious 
associations between genes and outcomes may arise through population stratification if 
samples are made up of populations of more than one ancestry, which have different allele 
frequencies and different levels of disease outcomes [19]. Therefore, care should be taken 
to identify and appropriately control for genetic ancestry. Confounding may also arise if the 
variant has pleiotropic effects which influence the outcome other than through the exposure 
of interest, or if the variant is in linkage disequilibrium with another genetic variant which also 
influences the outcome [20]. In such cases, one cannot be confident that any “causal” effect 
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observed operates through the exposure of interest. In some MR studies of lifestyle 
behaviours, it may be possible to perform a test of pleiotropy by investigating associations of 
the genetic variant with the outcome in individuals not exposed to the behaviour. This has 
been demonstrated in MR studies of alcohol use in East Asians, which have stratified 
analyses by sex. The alcohol-related variant influences blood pressure in males (who 
consume alcohol) but not in females (who tend not to consume alcohol in many East Asian 
cultures for social and historical reasons), indicating that the likely mechanism of the genetic 
effect on blood pressure is through alcohol consumption [34]. However, whilst stratifying on 
an exogenous variable such as sex, as described above, can be a useful tool in some MR 
studies, care must be taken not to reintroduce confounding through collider bias [35,36]. This 
can occur when MR analyses are stratified on the measured exposure of interest and can 
amplify or mask associations between the genetic variant and outcome within the exposure 
strata [37]. 
A further potential concern is the possibility of canalization, which is the process of 
developmental compensation to buffer against the effects of disruptive genetic or 
environmental influences during development [9]. If exposure to elevated levels of a risk 
factor during foetal development or post-natal growth results in tissue changes which 
compensate for this, the genetic variant will still associate with the risk factor of interest, but 
any potential effects on a disease outcome may be reduced. However, canalization is less 
problematic for exposures which tend to occur later in development, such as smoking and 
alcohol consumption [7]. 
There are a number of other statistical issues in relation to MR, particularly 
surrounding the use of two-stage instrumental variable analysis (e.g., weak instrument bias). 
These are beyond the scope of this review, but are discussed in detail elsewhere [38-40]. 
 
Conclusions 
 Inferring causation from observational data is notoriously problematic. Although MR 
relies on certain assumptions that may not always apply, it nevertheless has the potential to 
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dramatically advance our understanding of the causal role of modifiable environmental 
exposures on a variety of outcomes. As genome-wide association studies continue to reveal 
variants associated with a range of behavioural phenotypes, the applications of MR will 
grow. In particular, risk scores that capture a substantial proportion of the phenotypic 
variation in behavioural outcomes will enable us to apply MR more extensively, by providing 
stronger instruments. Genome-wide association studies have enjoyed substantial success in 
many areas, and are beginning to realise similar success for other phenotypes (e.g., 
psychiatric outcomes such as schizophrenia) where understanding the causal role of these 
phenotypes will be of considerable scientific and societal importance. 
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Figure 1. Randomization by Intervention and Genetics. 
 
 
 
 
Figure from Davey Smith and Ebrahim, 2005 [10]. Reproduced with permission. 
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Figure 2. Principles of Mendelian Randomization. 
 
 
 
A directed acyclic graph illustrating the principles of Mendelian randomization is shown. 
Genotype is associated with the risk factor, but not the putative outcome or potential 
confounders. 
  
instrument 
(genetic variant) 
(modifiable) risk factor outcome 
confounders 
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Figure 3. Applications of Mendelian Randomization 
 
 
 
The direct association between genetic variant and outcome (A) provides evidence for the 
existence of a causal relationship. The magnitude of the causal association between 
measured exposure and outcome (C) is calculated from the association between genetic 
variant and outcome (A) and the association between genetic variant and measured 
exposure (B).  
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Figure 4. Two-Step Epigenetic Mendelian Randomization 
 
Dashed lines represent causal associations investigated at each step. In Step 1, a genetic 
variant associated with the exposure is used to investigate whether the exposure is causally 
associated with DNA methylation at a particular locus. In Step 2, a genetic variant 
associated with DNA methylation at the locus of interest is used to investigate whether DNA 
methylation is causally associated with the outcome. Diagram adapted from Relton and 
Davey Smith, 2012 [22].  Reproduced with permission.   
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Text Box 1. The CARTA Consortium 
The consortium for Causal Analysis Research in Tobacco and Alcohol (CARTA; 
http://www.bris.ac.uk/expsych/research/brain/targ/research/collaborations/carta/) was 
established at the University of Bristol to investigate the causal effects of tobacco use, 
alcohol use and other lifestyle factors on health and sociodemographic outcomes using MR. 
CARTA includes over 30 studies, spanning nine countries, with a total sample size in excess 
of 150,000 – given the relatively small effects that individual genetic variants exert on 
exposures, MR generally requires very large sample sizes. CARTA has completed five initial 
analyses, investigating the impact of cigarette smoking on depression and anxiety, regional 
adiposity, blood pressure and heart rate, serum vitamin D levels and income. The genetic 
variant used as a proxy for this exposure was rs16969968, a genetic variant which is 
robustly associated with smoking heaviness in smokers [1-3,32,41,42]. Results of these 
initial analyses are currently in preparation. 
 
 
